日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report

在接受menin抑制剂治疗前,NPM1突变或KMT2A重排的AML老年患者的临床结局:Beat AML报告

Zeidner, Joshua F; Jain, Jayanshu; Welkie, Rina Li; Huang, Ying; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Madanat, Yazan F; Collins, Robert H; Baer, Maria R; Duong, Vu H; Blum, William G; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Handa, Shivani; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Mims, Alice S; Byrd, John C; Borate, Uma

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML

阿扎胞苷、维奈托克和瑞伐美尼用于新诊断的NPM1突变或KMT2A重排急性髓系白血病

Zeidner, Joshua F; Lin, Tara L; Welkie, Rina Li; Curran, Emily; Koenig, Kristin; Stock, Wendy; Madanat, Yazan F; Swords, Ronan; Baer, Maria R; Blum, William; Stein, Eytan M; Olin, Rebecca L; Schiller, Gary; Nichols, Angela; Odenike, Olatoyosi; Traer, Elie; Lachowiez, Curtis; Duong, Vu H; Hochman, Michael J; Cai, Sheng F; Smith, Catherine; Stefanos, Mona; Martycz, Molly; Huang, Ying; Rosenberg, Len; Marcus, Sonja; Chen, Timothy L; Yocum, Ashley O; Druker, Brian J; Levine, Ross L; Borate, Uma; Byrd, John C; Mims, Alice S

Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study

Magrolimab联合阿扎胞苷与医生选择方案治疗未经治疗的TP53突变型急性髓系白血病:ENHANCE-2研究

Zeidner, Joshua F; Sallman, David A; Récher, Christian; Daver, Naval G; Leung, Anskar Y H; Hiwase, Devendra K; Subklewe, Marion; Pabst, Thomas; Montesinos, Pau; Larson, Richard A; Wilde, Lindsay; Enjeti, Anoop K; Kawashima, Ichiro; Papayannidis, Cristina; O'Nions, Jenny; Johnson, Lisa; Dong, Mei; Huang, Julie; Bagheri, Taravat; Hacohen Kleiman, Gal; Lee, Calvin; Vyas, Paresh

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

对60岁及以上新诊断急性髓系白血病患者进行分子特征分析:来自Beat AML临床试验的报告

Hoff, Fieke W; Huang, Ying; Welkie, Rina Li; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Patel, Prapti A; Collins, Robert H Jr; Baer, Maria R; Duong, Vu H; Blum, William G; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L; Kovacsovics, Tibor; Deininger, Michael W; Zeidner, Joshua F; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Koenig, Kristin L; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Borate, Uma M; Mims, Alice S; Byrd, John C; Madanat, Yazan F

Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide

优化急性髓系白血病低强度三联疗法:实用指南

Jen, Wei-Ying; Lachowiez, Curtis A; Marvin-Peek, Jennifer; Altman, Jessica K; Yilmaz, Musa; Garcia, Jacqueline S; Abaza, Yasmin; Short, Nicholas J; Zeidner, Joshua F; Daver, Naval G; Wei, Andrew H; Issa, Ghayas C; DiNardo, Courtney D

Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study

维奈托克治疗急性髓系白血病临床结局的遗传和表型相关性:GEN-PHEN-VEN 研究

Lachowiez, Curtis A; Heiblig, Mael; Aspas Requena, Gaspar; Tavernier-Tardy, Emmanuelle; Dai, Fangyan; Ashango, Amenech B; Peters, Daniel T; Fang, Jacob; Kaempf, Andy; Long, Nicola; Eide, Christopher A; Kurtz, Stephen E; Xie, Wei; Agarwal, Anupriya; Sahasrabudhe, Aishwarya; McMahon, Christine M; Amaya, Maria L; Meyers, Gabrielle; Gandhi, Arpita; Leonard, Jessica; Hayes-Lattin, Brandon; Maziarz, Richard T; Traer, Elie; Cook, Rachel J; Swords, Ronan; Braun, Theodore P; Saultz, Jennifer N; Eckel, Ashley M; Loken, Michael R; Zeidner, Joshua F; Tyner, Jeffrey W; Pollyea, Daniel A

A second look at the status quo for secondary acute myeloid leukemia after hypomethylating agents

对去甲基化药物治疗后继发性急性髓系白血病现状的再次审视

Peters, Daniel T; Zeidner, Joshua F

Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity

靶向 PRMT9 介导的精氨酸甲基化可抑制癌症干细胞维持并引发 cGAS 介导的抗癌免疫

Haojie Dong #, Xin He #, Lei Zhang #, Wei Chen, Yi-Chun Lin, Song-Bai Liu, Huafeng Wang, Le Xuan Truong Nguyen, Min Li, Yinghui Zhu, Dandan Zhao, Lucy Ghoda, Jonathan Serody, Benjamin Vincent, Leo Luznik, Ivana Gojo, Joshua Zeidner, Rui Su, Jianjun Chen, Ritin Sharma, Patrick Pirrotte, Xiwei Wu, Wei

Risk prediction for clonal cytopenia: multicenter real-world evidence

克隆性血细胞减少症风险预测:多中心真实世界证据

Xie, Zhuoer; Komrokji, Rami; Al Ali, Najla; Regelson, Alexandra; Geyer, Susan; Patel, Anand; Saygin, Caner; Zeidan, Amer M; Bewersdorf, Jan Philipp; Mendez, Lourdes; Kishtagari, Ashwin; Zeidner, Joshua F; Coombs, Catherine C; Madanat, Yazan F; Chung, Stephen; Badar, Talha; Foran, James; Desai, Pinkal; Tsai, Charlton; Griffiths, Elizabeth A; Al Malki, Monzr M; Amanam, Idoroenyi; Lai, Catherine; Deeg, H Joachim; Ades, Lionel; Arana Yi, Cecilia; Osman, Afaf E G; Dinner, Shira; Abaza, Yasmin; Taylor, Justin; Chandhok, Namrata; Soong, Deborah; Brunner, Andrew M; Carraway, Hetty E; Singh, Abhay; Elena, Chiara; Ferrari, Jacqueline; Gallì, Anna; Pozzi, Sara; Padron, Eric; Patnaik, Mrinal M; Malcovati, Luca; Savona, Michael R; Al-Kali, Aref

Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)

社论:急性髓系白血病(AML)和急性淋巴细胞白血病(ALL)的免疫疗法

Jamy, Omer; Zhou, Fuling; Zeidner, Joshua